Palisade Bio, Inc.
PALI· Nasdaq
Nov 16, after the close
Mon, Nov 16, 2026in 16 days
Projected from its last 8 releases. The company has not named the day yet.
Up after 8 of 12, down after 4.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Based on 8 prior 10-Q filings.
The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: +8.1% after Q4 2023.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.